Robo Global Healthcare Technology and… (HTEC) Holdings
HTEC holdings summary
as of Oct 24, 2026- Holdings
- 61 positions listed
- Top 10 weight
- 22.0% of net assets
- Effective holdings
- 58 equal-weight equivalent
- Largest holding
- GRAL 2.61% GRAIL, Inc.
- Annual turnover
- 0.0% of the portfolio traded
All HTEC holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | GRAL | GRAIL, Inc. | Healthcare | 2.61% | $2.9M | $5.26B | — |
| 2 | NTRA | Natera, Inc. | Healthcare | 2.46% | $2.7M | $56.71B | — |
| 3 | MRNA | Moderna, Inc. | Healthcare | 2.40% | $2.7M | $87.04B | — |
| 4 | ISRG | Intuitive Surgical, Inc. | Healthcare | 2.31% | $2.6M | $150.74B | 48.9 |
| 5 | TWST | Twist Bioscience Corporation | Healthcare | 2.25% | $2.5M | $8.80B | — |
| 6 | ILMN | Illumina, Inc. | Healthcare | 2.08% | $2.3M | $39.64B | 49.0 |
| 7 | TMO | Thermo Fisher Scientific Inc. | Healthcare | 2.05% | $2.3M | $255.13B | 37.1 |
| 8 | MEDP | Medpace Holdings, Inc. | Healthcare | 1.95% | $2.2M | $17.26B | 36.3 |
| 9 | LONN | Lonza Group AG | Healthcare | 1.95% | $2.2M | — | — |
| 10 | SHL | Siemens Healthineers AG | Healthcare | 1.95% | $2.2M | — | — |
| 11 | SYK | Stryker Corporation | Healthcare | 1.93% | $2.1M | $113.02B | 30.5 |
| 12 | CDNA | CareDx, Inc | Healthcare | 1.91% | $2.1M | $3.31B | 30.8 |
| 13 | GH | Guardant Health, Inc. | Healthcare | 1.86% | $2.1M | $21.28B | — |
| 14 | TEM | Tempus AI, Inc. | Healthcare | 1.83% | $2.0M | $11.68B | — |
| 15 | LIVN | LivaNova PLC | Healthcare | 1.83% | $2.0M | $4.26B | 23.0 |
| 16 | PHIA | Koninklijke Philips NV | Healthcare | 1.83% | $2.0M | — | — |
| 17 | TECN | Tecan Group AG | Healthcare | 1.80% | $2.0M | — | — |
| 18 | DHR | Danaher Corporation | Healthcare | 1.77% | $2.0M | $161.01B | 40.8 |
| 19 | BSX | Boston Scientific Corporation | Healthcare | 1.76% | $2.0M | $64.33B | 18.0 |
| 20 | IQV | IQVIA Holdings Inc. | Healthcare | 1.75% | $1.9M | $43.93B | 33.2 |
| 21 | ADPT | Adaptive Biotechnologies Corporation | Healthcare | 1.74% | $1.9M | $3.83B | — |
| 22 | GMED | Globus Medical, Inc. | Healthcare | 1.73% | $1.9M | $10.30B | 19.7 |
| 23 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 1.73% | $1.9M | $81.41B | 19.6 |
| 24 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 1.73% | $1.9M | $126.66B | 28.9 |
| 25 | A | Agilent Technologies, Inc. | Healthcare | 1.72% | $1.9M | $48.77B | 34.1 |
| 26 | 6618 | Jd Health International Inc | Healthcare | 1.72% | $1.9M | — | — |
| 27 | PEN | Penumbra, Inc. | Healthcare | 1.71% | $1.9M | $12.64B | 78.8 |
| 28 | ERF | Eurofins Scientific SE | Healthcare | 1.70% | $1.9M | — | — |
| 29 | INCY | Incyte Corporation | Healthcare | 1.70% | $1.9M | $22.92B | 14.4 |
| 30 | GKOS | Glaukos Corporation | Healthcare | 1.67% | $1.8M | $9.72B | — |
| 31 | QGEN | Qiagen N.V. | Healthcare | 1.66% | $1.8M | $9.53B | 23.4 |
| 32 | ROP | Roche Holding AG | Healthcare | 1.65% | $1.8M | — | — |
| 33 | CRL | Charles River Laboratories International, Inc. | Healthcare | 1.61% | $1.8M | $14.46B | — |
| 34 | EW | Edwards Lifesciences Corporation | Healthcare | 1.60% | $1.8M | $49.92B | 51.5 |
| 35 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | 1.60% | $1.8M | $31.02B | 39.1 |
| 36 | VCYT | Veracyte, Inc. | Healthcare | 1.59% | $1.8M | $3.47B | 30.8 |
| 37 | CRSP | CRISPR Therapeutics AG | Healthcare | 1.59% | $1.8M | $4.76B | — |
| 38 | UTHR | United Therapeutics Corporation | Healthcare | 1.59% | $1.8M | $22.87B | 19.1 |
| 39 | GEHC | GE HealthCare Technologies Inc. | Healthcare | 1.58% | $1.8M | $31.42B | 16.0 |
| 40 | ABT | Abbott Laboratories | Healthcare | 1.52% | $1.7M | $181.50B | 33.8 |
| 41 | BDX | Becton, Dickinson and Company | Healthcare | 1.52% | $1.7M | $52.23B | 44.6 |
| 42 | DIA | DiaSorin S.p.A. | Healthcare | 1.44% | $1.6M | — | — |
| 43 | IRTC | iRhythm Technologies, Inc. | Healthcare | 1.43% | $1.6M | $3.58B | — |
| 44 | NVCR | NovoCure Limited | Healthcare | 1.42% | $1.6M | $1.64B | — |
| 45 | NOVT | Novanta Inc. | Technology | 1.40% | $1.5M | $4.87B | 81.5 |
| 46 | AXGN | AxoGen, Inc. | Healthcare | 1.37% | $1.5M | $2.03B | — |
| 47 | RVTY | Revvity, Inc. | Healthcare | 1.29% | $1.4M | $17.03B | 73.0 |
| 48 | BIO | Bio-Rad Laboratories, Inc. | Healthcare | 1.28% | $1.4M | $9.46B | 44.8 |
| 49 | BMY | Bristol-Myers Squibb Company | Healthcare | 1.28% | $1.4M | $122.05B | 13.2 |
| 50 | ARWR | Arrowhead Pharmaceuticals, Inc. | Healthcare | 1.27% | $1.4M | $7.90B | — |
| 51 | CNMD | CONMED Corporation | Healthcare | 1.25% | $1.4M | $1.40B | 25.3 |
| 52 | VEEV | Veeva Systems Inc. | Healthcare | 1.23% | $1.4M | $50.25B | 50.9 |
| 53 | AORT | Artivion, Inc. | Healthcare | 1.19% | $1.3M | $1.06B | — |
| 54 | OMCL | Omnicell, Inc. | Healthcare | 1.18% | $1.3M | $1.61B | 42.1 |
| 55 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | 1.18% | $1.3M | $10.58B | 147.8 |
| 56 | SN | Smith & Nephew PLC | Healthcare | 1.16% | $1.3M | — | — |
| 57 | 4587 | PeptiDream Inc | Healthcare | 1.14% | $1.3M | — | — |
| 58 | 0241 | Alibaba Health Information Technology Ltd | Healthcare | 1.01% | $1.1M | — | — |
| 59 | IART | Integra LifeSciences Holdings Corporation | Healthcare | 1.01% | $1.1M | $1.03B | — |
| 60 | CMPS | COMPASS Pathways plc | Healthcare | 0.99% | $1.1M | $1.49B | — |
| 61 | AGPXX | Invesco Short-Term Investments Trust Government & Agency Portfolio Institutional | Other | 0.41% | $449,698.35 | — | — |
Weights as a percentage of net assets. Value held = weight × net assets ($110.7M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
HTEC sector breakdown
| Sector | Weight | Holdings | Largest |
|---|---|---|---|
| Healthcare | 97.0% | 59 | GRAL, NTRA, MRNA |
| Technology | 1.4% | 1 | NOVT |
| Other | 0.4% | 1 | AGPXX |
Sum of the weights of the holdings in each sector.
HTEC top industries
HTEC overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| VTI | Vanguard Total Stock Market ETF | 2.6% | 47 of 2,941 | 0.03% |
| SPY | SPDR S&P 500 ETF | 2.6% | 21 of 502 | 0.09% |
| QQQ | Invesco QQQ ETF | 2.4% | 7 of 101 | 0.17% |
| IWM | iShares Russell 2000 ETF | 2.1% | 16 of 1,962 | 0.19% |
| VXUS | Vanguard Total International Stock ETF | 1.0% | 14 of 8,035 | 0.05% |
| DIA | SPDR Dow Jones Industrial Average ETF | 0.0% | 0 of 30 | 0.16% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the HTEC portfolio
Robo Global Healthcare Technology and… holds 61 positions. The ten largest make up 22.0% of the fund and the top 50 87.1%, so it behaves like a portfolio of about 58 equally weighted stocks. The biggest positions are GRAIL, Inc. (2.61%), Natera, Inc. (2.46%), Moderna, Inc. (2.40%), Intuitive Surgical, Inc. (2.31%), Twist Bioscience Corporation (2.25%).
By sector, Healthcare is 97.0%, Technology is 1.4%, Other is 0.4%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 24, 2026; positions change as the fund rebalances.
Related: HTEC chart, HTEC performance, HTEC dividends, HTEC valuation, HTEC overview.
HTEC holdings FAQ
How many holdings does HTEC have?
HTEC holds 61 positions as of October 24, 2026.
What are the top 10 holdings of HTEC?
The ten largest holdings are GRAIL, Inc. (2.61%), Natera, Inc. (2.46%), Moderna, Inc. (2.40%), Intuitive Surgical, Inc. (2.31%), Twist Bioscience Corporation (2.25%), Illumina, Inc. (2.08%), Thermo Fisher Scientific Inc. (2.05%), Medpace Holdings, Inc. (1.95%), Lonza Group AG (1.95%), Siemens Healthineers AG (1.95%). Together they are 22.0% of the fund.
What percentage of HTEC is GRAIL, Inc.?
GRAIL, Inc. is the largest holding at 2.61% of net assets, about $2.9M of the fund's $110.7M.
Which sector is the largest in HTEC?
Healthcare is the largest sector at 97.0%, followed by Technology (1.4%) and Other (0.4%), based on the sectors of the individual holdings.
How concentrated is HTEC?
The top 10 holdings are 22.0% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) HTEC behaves like a portfolio of about 58 equally weighted stocks.